BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17935486)

  • 1. Function of the N-terminus of zizimin1: autoinhibition and membrane targeting.
    Meller N; Westbrook MJ; Shannon JD; Guda C; Schwartz MA
    Biochem J; 2008 Jan; 409(2):525-33. PubMed ID: 17935486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel Cdc42 guanine nucleotide exchange factor, zizimin1, dimerizes via the Cdc42-binding CZH2 domain.
    Meller N; Irani-Tehrani M; Ratnikov BI; Paschal BM; Schwartz MA
    J Biol Chem; 2004 Sep; 279(36):37470-6. PubMed ID: 15247287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of dendrite growth by the Cdc42 activator Zizimin1/Dock9 in hippocampal neurons.
    Kuramoto K; Negishi M; Katoh H
    J Neurosci Res; 2009 Jun; 87(8):1794-805. PubMed ID: 19156867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zizimin1, a novel Cdc42 activator, reveals a new GEF domain for Rho proteins.
    Meller N; Irani-Tehrani M; Kiosses WB; Del Pozo MA; Schwartz MA
    Nat Cell Biol; 2002 Sep; 4(9):639-47. PubMed ID: 12172552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CZH proteins: a new family of Rho-GEFs.
    Meller N; Merlot S; Guda C
    J Cell Sci; 2005 Nov; 118(Pt 21):4937-46. PubMed ID: 16254241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a DOCK180-related guanine nucleotide exchange factor that is capable of mediating a positive feedback activation of Cdc42.
    Lin Q; Yang W; Baird D; Feng Q; Cerione RA
    J Biol Chem; 2006 Nov; 281(46):35253-62. PubMed ID: 16968698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro guanine nucleotide exchange activity of DHR-2/DOCKER/CZH2 domains.
    Côté JF; Vuori K
    Methods Enzymol; 2006; 406():41-57. PubMed ID: 16472648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zizimin2: a novel, DOCK180-related Cdc42 guanine nucleotide exchange factor expressed predominantly in lymphocytes.
    Nishikimi A; Meller N; Uekawa N; Isobe K; Schwartz MA; Maruyama M
    FEBS Lett; 2005 Feb; 579(5):1039-46. PubMed ID: 15710388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A minimal Rac activation domain in the unconventional guanine nucleotide exchange factor Dock180.
    Wu X; Ramachandran S; Lin MC; Cerione RA; Erickson JW
    Biochemistry; 2011 Feb; 50(6):1070-80. PubMed ID: 21033699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Steric-inhibition model for regulation of nucleotide exchange via the Dock180 family of GEFs.
    Lu M; Kinchen JM; Rossman KL; Grimsley C; Hall M; Sondek J; Hengartner MO; Yajnik V; Ravichandran KS
    Curr Biol; 2005 Feb; 15(4):371-7. PubMed ID: 15723800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoinhibition mechanism of proto-Dbl.
    Bi F; Debreceni B; Zhu K; Salani B; Eva A; Zheng Y
    Mol Cell Biol; 2001 Mar; 21(5):1463-74. PubMed ID: 11238883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
    Wang L; Zhu K; Zheng Y
    Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the C-terminal SH3 domain and N-terminal tyrosine phosphorylation in regulation of Tim and related Dbl-family proteins.
    Yohe ME; Rossman K; Sondek J
    Biochemistry; 2008 Jul; 47(26):6827-39. PubMed ID: 18537266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of proto-Dbl by intracellular membrane targeting and protein stability.
    Vanni C; Mancini P; Gao Y; Ottaviano C; Guo F; Salani B; Torrisi MR; Zheng Y; Eva A
    J Biol Chem; 2002 May; 277(22):19745-53. PubMed ID: 11907027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth.
    Miyamoto Y; Yamauchi J; Sanbe A; Tanoue A
    Exp Cell Res; 2007 Feb; 313(4):791-804. PubMed ID: 17196961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of oncogenic DBL activity by phosphoinositol phosphate binding to pleckstrin homology domain.
    Russo C; Gao Y; Mancini P; Vanni C; Porotto M; Falasca M; Torrisi MR; Zheng Y; Eva A
    J Biol Chem; 2001 Jun; 276(22):19524-31. PubMed ID: 11278560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Rho GTPase-dependent sites in the Dbl homology domain of oncogenic Dbl that are required for transformation.
    Zhu K; Debreceni B; Li R; Zheng Y
    J Biol Chem; 2000 Aug; 275(34):25993-6001. PubMed ID: 10854437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific recognition of Rac2 and Cdc42 by DOCK2 and DOCK9 guanine nucleotide exchange factors.
    Kwofie MA; Skowronski J
    J Biol Chem; 2008 Feb; 283(6):3088-3096. PubMed ID: 18056264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors.
    Kulkarni K; Yang J; Zhang Z; Barford D
    J Biol Chem; 2011 Jul; 286(28):25341-51. PubMed ID: 21613211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration.
    Murakami M; Meneses PI; Lan K; Robertson ES
    Cancer Biol Ther; 2008 May; 7(5):677-88. PubMed ID: 18728402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.